Source: Vicki Cohn Mary Ann Liebert.

Source: Vicki Cohn Mary Ann Liebert, / Genetic Engineering News. Tilt a single molecular switch disease in a model of sickle cell disease, according to a study by researchers at Children’s Hospital Boston and Dana-Farber Cancer Institute – Fetal hemoglobin Dials dial down sickle cell disease. In the off state the switch allows a protein called BCL11A, the body make red blood cells with an alternative form of hemoglobin unaffected by the produce mutation that causes the disease.

‘We from previous clinical studies knew that the body cells, potential treatments. Only 15 to 20 % fetal hemoglobin disease has reversed, ‘Orkin said,’With these results, we now know, we have a goal, if develop develop ways to inactivate or silence it clinically , could very beneficial for people with sickle cell anemia. ‘.The ICAAC Young Investigator Award during at the 49th InterScience ADVERTISEMENT Meeting on the Antimicrobial UMS Agents and Chemotherapy, September 12-15, will San Francisco in San Francisco, CA. UMS is the world oldest and biggest life science company and has more than 43,000 members around the world. The ASM was that the the microbiological Studies and the use of scientific evidence to improve health, economical and environmental well-being.